Mesenchymal stem cells (MSC) are capable of multipotent differentiation into connective tissues and as such are an attractive source for autologous cell-based treatments for many clinical diseases and injuries. Ageing is associated with various altered cellular phenotypes coupled with a variety of transcriptional, epigenetic and translational changes. Furthermore, the regeneration potential of MSCs is reduced with increasing age and is correlated with changes in cellular functions. This study used a systems biology approach to investigate the transcriptomic (RNASeq), epigenetic (miRNASeq and DNA methylation) and protein alterations in ageing MSCs in order to understand the age-related functional and biological variations, which may affect their applications to regenerative medicine. We identified no change in expression of the cellular senescence markers. Alterations were evident at both the transcriptional and post-transcriptional level in a number of transcription factors. There was enrichment in genes involved in developmental disorders at mRNA and differential methylated loci (DML) level. Alterations in energy metabolism were apparent at the DML and protein level. The microRNA miR-199b-5p, whose expression was reduced in old MSCs, had predicted gene targets involved in energy metabolism and cell survival. Additionally, enrichment of DML and proteins in cell survival was evident. Enrichment in metabolic processes was revealed at the protein level and in genes identified as undergoing alternate splicing. Overall, an altered phenotype in MSC ageing at a number of levels implicated roles for inflammageing and mitochondrial ageing. Identified changes represent novel insights into the ageing process, with implications for stem cell therapies in older patients.
Introduction
Mesenchymal stem cells (MSC) are post-embryonic cells, capable of self-renewal and multipotent differentiation into connective tissues including bone, tendon and cartilage. They are an attractive source for autologous cell-based treatments for a range of clinical diseases and injuries. Furthermore, these cells may be considered useful tools for understanding the physiopathological understanding of specific diseases, and to develop disease-specific biomarkers (Valenti et al., 2015) .
MSCs possess an age-related loss of cellular functions, including differentiation potential and capacity for proliferation (Huang et al., 2010; Kretlow et al., 2008; Yu et al., 2011) . This has implications for stem cell therapies in older patients. Moreover, the reduction in differentiation potential could contribute to ageing and age-related disease (Zaim et al., 2012) . It has become increasingly apparent that the therapeutic efficacy mediated by MSCs is through the production of soluble factors (cytokines and growth factors) that control diverse disease-associated processes, including activation of tissue resident stem cells, apoptosis and inhibition of inflammation (Kolf et al., 2007) .
Ageing is a complex process with effects at both the cellular and organism level. Ageing has been defined as "the sum of the primary restrictions in regenerative mechanisms of multicellular organisms" (Sethe et al., 2006) . It presents huge challenges for society, but a key issue is that whilst life span increases, quality of life faced by individuals in old age is often poor. As MSCs provide regenerative capacity it is rational that functional deficiencies may contribute to the ageing process and age-related diseases such as osteoarthritis, osteoporosis and tendinopathy.
Natural ageing is coupled with a progressive reduction in the regulation of cellular, tissue and organ interactions, resulting in senescence (the irreversibly arrest of cellular division). It can affect the decline in regenerative potential of tissue and cellular functions in numerous organs. Animal studies and clinical trials have demonstrated that the regeneration potential of bone (Stenderup et al., 2004) and other tissues declines with age due to a reduced number or frequency of stem cells present in adult organs. These factors could contribute to human ageing and age-related disease (Rando, 2006) . Thus, understanding the age-related functional and biological alterations in MSCs will be decisive to the success of therapeutic application of MSCs. Furthermore, it is proposed that long-term culture and www.ecmjournal.org MJ Peffers et al. MSC multi-omics ageing may be regulated by similar mechanisms (Wagner et al., 2009) . A number of studies have investigated biological ageing on MSCs (reviewed by: Oh et al., 2014; Sethe et al., 2006; Stolzing et al., 2008) . The cell number (Kasper et al., 2009; Sethe et al., 2006) , potential to proliferate and differentiate (Kretlow et al., 2008; Zaim et al., 2012) , frequency of colony forming units (Baxter et al., 2004) and senescence-associated beta-galactosidase are age-related. Additionally, MSC ageing is affected by oxidative stress (Stolzing et al., 2006) , DNA damage (Beausejour, 2007) , telomere shortening (Beausejour, 2007) and apoptosis (Stolzing et al., 2008) . Using microarrays differentially expressed genes engaged in cell cycle. DNA replication and repair have been identified as age-related (Hacia et al., 2008; Yu et al., 2011) , whilst a number of miRs are differentially expressed in MSC ageing (Pandey et al., 2011; Wagner et al., 2008; Yu et al., 2011) . Global proteomic studies of biological MSC ageing have been scarce, although studies have investigated in vitro ageing (Madeira et al., 2012) and MSCs in old osteoarthritis patients (Camafeita et al., 2014; Rollin et al., 2008) . However, one study in the rat identified age-affected susceptibility towards senescence, and molecular functions associated with cytoskeleton organisation and antioxidant defence (Kasper et al., 2009) . Previous studies have shown that genes involved in cell signalling, apoptosis and cell death undergo differential methylation in late passage MSCs when compared to early passage MSCs (Choi et al., 2012; Redaelli et al., 2012) . In addition, analysis of methylation in biological ageing identified differentially methylated homeobox genes and genes pertinent to cell differentiation (Bork et al., 2010) .
Important bio-molecules in MSC ageing consist of the genes functioning as the information source defining limits of cell behaviour. Some of this information is processed through transcription, forming mRNA. This can be regulated by methylation and miRNA epigenetic control. mRNA transcription enables the production of proteins, the effector molecules that control the cellular state and behaviour. The purpose of this study was to investigate the global epigenetic (DNA-methylation and miRNA), RNA and protein changes in biological ageing of MSCs in a bid to understand the age-related functional and biological changes impacting upon their therapeutic applications in regenerative medicine and use as disease-specific biomarkers. The identification of individual transcripts, functionally coherent gene sets, or proteins that are underor over-expressed with ageing may provide key insights into the mechanisms of ageing processes and age-related disease.
Materials and Methods
Mesenchymal stem cell culture Human MSCs were purchased from young; n = 4 (21.8 y ± 2.4 SD) (Stem Cell Technologies, Grenoble, France) and old; n = 4 (65.5 y ± 8.3 SD) (Promocell, Heidelberg, Germany) donors and RNA, DNA and protein extracted following 8 population doublings. MSCs were incubated to passage 4 in 5 % oxygen, as previously described (Peffers et al., 2010) . Briefly, they were grown as monolayers in Dulbecco's modified eagles medium (DMEM) (Invitrogen, Paisley, UK), supplemented with 10 % foetal calf serum, 100 units/mL penicillin, 100 mg/ mL streptomycin (all from Invitrogen, Paisley, UK) and 500 ng/mL amphotericin B (BioWhittaker, Lonza, USA).
RNA isolation, library preparation for RNASeq and small RNASeq and sequencing
Total RNA was isolated from approximately two million cells using TRIzol (Invitrogen™ Life Technologies, Carlsbad, USA) (Chomczynski and Sacchi, 1987) . RNA was purified using RNeasy spin columns with on-column DNase treatment (Qiagen, Crawley, UK) to remove residual gDNA, according to the manufacturer's instructions. RNA-Seq and small RNASeq library preparations and sequencing was undertaken by the Centre for Genomic Research, University of Liverpool. Sequencing used the Illumina HiSeq 2000 (Illumina, San Diego, USA) at 2 × 100-base pair (bp) paired-end sequencing with v3 chemistry for RNASeq. Multiplexed size selected small RNA library pools were sequenced on one lane of the Illumina HiSeq 2500 (Illumina, San Diego, USA) at 1 × 50 bp sequencing.
Total RNA integrity was confirmed, using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA). Ribosomal RNA (rRNA) was depleted from 8 total RNA samples by using the Ribo-Zero™ rRNA Removal Kit (Epicentre, Madison, USA) in accordance with manufacturer's instructions. For RNASeq cDNA libraries were prepared with the ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre, Madison, USA) using 50 ng rRNA depleted RNA as starting material in accordance with manufacturer's protocols, as previously described (Peffers et al., 2013a) . For both RNASeq and small RNASeq (smallSeq), the quantity and quality of the final pools were assessed using Qubit (Invitrogen™ Life Technologies, USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA). The final pooled library was diluted to 8 pmol before hybridisation. Sequencing was undertaken with the Illumina HiSeq 2000 (Illumina, San Diego, USA) at 2 × 100-base pair (bp) paired-end sequencing with v3 chemistry. 1 μg of total RNA were used to prepare small RNA libraries using the NEBNextMultiplex Small RNA Library Preparation Set for Illumina (New England BioLabs, Ipswich, USA), according to manufacturer's instructions. Following 12 cycles of amplification, the PCR amplified cDNA constructs were purified using the Qiagen QIAQuick PCR Purification kit (Qiagen, Crawley, UK). Multiplexed size selected small RNA library pools were sequenced on one lane of the Illumina HiSeq 2500 (Illumina, San Diego, USA) at 1 x 50 bp sequencing with rapid-run mode chemistry.
RNA data processing
The RNASeq data was processed as previously described (Peffers et al., 2013a) . Briefly, RNASeq sequence libraries were processed by using CASAVA version 1.8.2 to produce 100 bp paired-end sequence data in fastq format. The fastq files were processed and quality trimming performed. The
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trimmed R1-R2 read pairs, for each sample, were aligned to reference sequence (Web ref. 1) by using TopHat2 version 2.0.10 ( Kim et al., 2013) with default settings, except for the option -g 1. Read counts were obtained from the mapping results by using HTSeq-count and genome annotation (Web ref.2) . The differential gene expression analysis was performed on R platform by using the edgeR package (Robinson et al., 2010) and focused on the contrast of old and young donors. The count data were normalised across libraries by using trimmed mean M (TMM) values of the default methods edgeR. The tagwise dispersions were estimated and then used for logFC (log2 fold change) estimating and testing. Differentially expressed genes (DEGs) were extracted by applying the threshold false discovery rate (FDR) of less than 0.05 to adjusted p values, which were generated by using Benjamini and Hochberg approach (Benjamini and Hochberg, 1995) . In addition, FPKM (fragments per kilobase of exon per million fragments mapped) values were converted from count values for comparing expression levels among genes. For smallSeq base-calling and de-multiplexing of indexed reads was performed by CASAVA version 1.8.2 (Illumina, San Diego, USA) to produce data, in fastq format. The raw fastq files were trimmed to remove Illumina adapter sequences using Cutadapt version 1.2.1 (Martin, 2011) . The option "−O 3" was set, so the 3' end of any reads which matched the adapter sequence over at least 3 bp was trimmed. The reads were trimmed to remove low quality bases, using Sickle version 1.2 with a minimum window quality score of 20. After trimming, reads shorter than 10 bp were removed.
Trimmed R1 reads were mapped to mature human microRNA (miRNA) and other human small RNAs included in Affymetrix miRNA 4.0 arrays. Reads were mapped to the reference sequences using Bowtie2 version 2.1.0 (Langmead and Salzberg, 2012) . Single-end mapping was carried out using the "very-sensitive-local" set of options, which increases the sensitivity and accuracy of the alignment relative to the default parameters. In addition, FPKM (fragments per kilobase of exon per million fragments mapped) values were converted from count values for comparing expression levels among small RNAs.
For smallSeq DEGs and transcripts were extracted by applying the threshold FDR of less than 0.05 p values, which were generated by using Benjamini and Hochberg approach (Benjamini and Hochberg, 1995) and a 1.4 log 2 fold change (Log 2 FC). All sequence data produced in this study have been submitted to National Centre for Biotechnology Information Gene Expression Omnibus (NCBI GEO) under Array Express accession number E-MTAB-3427.
Genomic DNA isolation, bisulphite treatment and methylation profiling Genomic DNA was extracted from 2 million cells using the SureSelect gDNA Extraction Kit (Agilent, Santa Clara, USA) according to manufacturer's instructions, 500 ng of genomic DNA was then bisulphite converted using the EZ-96 DNA Methylation Kit (Zymo Research, Irvine, USA). DNA methylation profiling of the samples was carried out by Cambridge Genomic Services (Cambridge, UK), using the Illumina Infinium HumanMethylation450 Beadchip array (Illumina, Inc., San Diego, USA).
Methylation data processing
GenomeStudio (Illumina Inc., San Diego, USA) was used to extract the raw data. GenomeStudio provides the methylation data as β values: β = M/(M + U) (M represents the fluorescent signal of the methylation probe; U represents the signal of the unmethylated probe). β values range from 0 (no methylation) to 1 (100 % methylation). The raw methylation data was processed using R (version 3.0.1) and the Watermelon package (version 2.12) as has been previously described (Pidsley et al., 2013) . Probes with a detection p value > 0.01 were removed. Age-related differential methylation was defined as Benjamini-Hochberg corrected p value (Benjamini and Hochberg, 1995) < 0.01 and a mean methylation difference (Δ β score) ≥ 0.10 (10 %), as has been previously reported (Whitaker et al., 2013) .
Protein extraction, sample preparation and mass spectrometry Cell pellets containing 2 million cells were lysed using a probe sonicator in the presence of protease inhibitors (Complete protease Inhibitors EDTA-free, Roche, Lewes, UK. For each sample 100 μg protein was reduced, alkylated and trypsin digested (Peffers et al., 2013b) . Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed using a NanoAcquity™ ultraperformance LC (Waters, Manchester, UK) on-line to an LTQ-Orbitrap Velos mass spectrometer (Thermo-Fisher Scientific, Hemel Hempstead, UK) (Peffers et al., 2013b) , as previously described. The proteomics data were deposited to the ProteomeXchange Consortium (Vizcaino et al., 2014) via the PRIDE partner repository with the dataset identifier PXD001952.
LC-MS/MS analysis was performed using nanoAcquity™ ultraperformance LC (Waters, Manchester, UK) on-line to an LTQ-Orbitrap Velos mass spectrometer (Thermo-Fisher Scientific, Hemel Hempstead, UK), using an electrospray ionisation ion source containing a 10 μm coated Pico-tip emitter (Presearch Ltd., Basingstoke, UK). Aliquots of tryptic peptides equivalent to 300 ng of tendon fascicle protein were loaded onto a 180 μm × 20 mm C18 trap column (Waters) at 5 μL/min in 99 % solvent A (water plus 0.1 % formic acid) and 1 % solvent B (acetonitrile plus 1 % formic acid) for 5 min and subsequently back-flushed onto a C18 pre-equilibrated analytical column (75 μm × 15 mm Waters) using a flow rate of 0.3 μL/min. Xcalibur 2.0 software (ThermoElectron, Hemel Hempstead, UK) was used to operate the LTQ-Orbitrap Velos mass spectrometer in data-dependant acquisition mode. The survey scan was acquired in the Orbitrap with a resolving power set to 30,000 (at 400 m/z). MS/MS spectra were concurrently acquired on the 20 most intense ions from the high-resolution survey scan in the LTQ mass spectrometer. Charge state filtering > 1 was used where unassigned precursor ions were not selected for fragmentation. Fragmentation parameters in the LTQ mass spectrometer were: normalised collision energy, 30;
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Label-free quantification
For label-free quantification ageing MSCs the Thermo raw files of the acquired spectra from in-solution tryptic digests were analysed by the ProgenesisQI™ software (Version 1, Waters, Manchester, UK), as previously described (Peffers et al., 2013b) . Briefly, the top five spectra for each feature were exported from ProgenesisQI™ and utilised for peptide identification in PEAKS ® 7 (Bioinformtics Solutions Inc., Ontario, Canada) using the Unihuman database. Search parameters used were: 10 ppm peptide mass tolerance and 0.6 Da fragment mass tolerance; one missed cleavage allowed; fixed modification, carbamidomethylation; variable modifications, methionine oxidation. Proteins were identified with a false discovery rate (FDR) of 1 % and a minimum of two peptides per protein. The resulting peptide-spectrum matches were imported into ProgenesisQI™ for label-free relative quantification. Differentially expressed proteins were defined with FDR p < 0.05 and ± 2-fold regulation.
Functional analysis of transcriptomic, proteomic and methylation data
To determine gene ontology, functional analyses, networks, canonical pathways and protein-protein interactions of age-related differentially expressed genes, methylated genes and proteins we performed the analyses using Panther Classification System (Mi et al., 2013) , the functional analysis and clustering tool from the Database for Annotation, Visualisation, and Integrated Discovery (DAVID bioinformatics resources 6.7) (Huang et al., 2009) (Franceschini et al., 2013) , as previously described (Peffers et al., 2013a; Peffers et al., 2015) . Targetscan v6.2 (Web ref. 4) was used to identify potential targets of miR-199.
Relative gene expression using real-time polymerase chain reaction (qRT-PCR) qRT-PCR was undertaken on similarly sourced MSCs at P4 from an independent cohort from those used for the RNA-Seq analysis young; n = 3 (22.2 y ± 2.3 SD) and old; n = 3 (64.8 y ± 6.6 SD) using methods previously described (Peffers et al., 2015) . Primers were either validated in previous publications (Bracken et al., 2003; Conklin et al., 2012; Martin, 2011; Peffers et al., 2015) and supplied by Eurogentec (Seraing, Belgium) or were designed and validated commercially (Primer Design, Southampton, UK). Steady-state transcript abundance of potential endogenous control genes was measured in the RNA-Seq data. Assays for four genes -Glutaraldehyde Table 3 . Summary of small RNA sequence alignment to the human genome. dehydrogenase (GAPDH), ribosomal protein 13 (RPS8), ribosomal protein 13 (RPS13), and ribosomal protein 16 (RPS16) were selected as potential reference genes as their expression was unaltered. Stability of this panel of genes was assessed by applying a gene stability algorithm (Vandesompele et al., 2002) . RPS8 was selected as the most stable endogenous control gene. For miR-199b cDNA synthesis was performed using 100 ng RNA and miRscript RT kit II (Qiagen, Crawley, UK) according to the manufacturer's protocol. qRT-PCR analysis was performed
Fig. 1. Variation in t h e R N A S e q d a t a demonstrated by principal c o m p o n e n t a n a l y s i s (PCA) and hierarchical c l u s t e r i n g . ( A ) T h e
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using miRScript SybrGreen Mastermix (Qiagen, Crawley, UK) using Rnu-6u as the endogenous control. Relative expression levels were calculated by using the 2−ΔCt method (Livak and Schmittgen, 2001) . Primers pairs used in this study are listed (Table 1) .
Western blot validation
Validation studies were undertaken with the same independent cohort as for the relative gene expression studies using methods previously described using 20 μg protein (Peffers et al., 2013b) . Membranes were probed with primary antibodies against the following; rabbit polyclonal to SOD2 (1:1000, Enzo Life Sciences, Exeter, UK), and anti GAPDH-horseradish peroxidase (HRP) conjugate (1:10,000; Sigma, Dorset, UK). A HRP conjugated goat anti-rabbit secondary antibody was used at 1:2000 (Sigma, Dorset, UK).
Statistical analysis
Statistically significant differences in relative gene expression were identified using a Mann-Whitney U test. Differences in relative band intensity in immunoblotting identified with a Student's t-test. Statistical analyses were undertaken using S-Plus (version 7.0; Tibco Software Inc., Palo Alto, USA) and Excel (version 2007; Microsoft, Redmond, USA).
Results
Overview of RNASeq and smallSeq data
For the RNASeq data an average of 54.7 million pairs of 100 bp paired-end reads per sample was generated that aligned to the human reference sequence. Mapping results are summarised in Table 2 . Of the 63,152 human genes, between 40.5 % and 45.1 % had at least one read aligned. 13,595 genes had no reads aligned from any of the samples. This is similar to the output of other RNA-Seq studies (Peffers et al., 2013a; Peffers et al., 2015) . In the smallSeq data, an average of 8.2 million 50 bp single-end reads was generated. Based on data variation assessment, one young sample was classed as an outlier and so removed from subsequent data analysis. This represented 75.1 % of reads mapped. 2,267 human small RNAs (reference sequences) had at least one read aligned (between 1,041 and 1,586 in 7 different samples). 1,939 of the small RNAs had no reads aligned from any of the 7 samples. Mapping results are summarised in Table 3 and are similar to other small RNASeq studies (Buitrago et al., 2015; Yang et al., 2014) . Reads were used to estimate small RNA transcript expression of all samples using FPKM in order to identify the most abundant microRNAs (miRs) and small nucleolar RNAs (snoRNAs). Table 4 highlights the top 10 highly expressed small RNAs genes within each class.
Identification of differentially expressed genes and differentially spliced genes using RNASeq
For RNASeq a principal component analysis (PCA) plot of log 2 gene expression data identified biological variation within both sample groups indicating that the age-effect is weak. The variability between old donors was greatest (Fig.  1A) . However, hierarchical clustering using a sample-tosample distance matrix identified clustering by age group (Fig. 1B) .
There were 46 differentially expressed transcribed elements between young and old, principally protein coding genes, but also three long non-coding RNAs (lncs) (per ± 1.4 log 2 fold change, FDR < 0.05). Of these 31 were higher in the older MSCs and 15 were lower (Table 5) . Table 4 . The top 10 most abundant small RNAs (CDBox, HAcaBox,scaRNAs, snoRNAs and miRs) within each class determined using FPKM.
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In total, 79,387 isoforms were detected in young and 77,189 isoforms were detected in old MSCs. No isoforms were differentially expressed. However, using Cuffdiff to calculate changes in the relative splice abundances by quantifying the square root of the Jensen-Shannon divergence on primary transcripts with at least two isoforms, identified 23 with differential splicing events (alternative splicing (AS)) (Table 6) .
For the smallSeq PCA of log 2 gene expression data indicated the age-effect was weak. The variability between old donors was greatest (Fig. 1C) . Hierarchical clustering clustered into young and old groups (Fig. 1D) . The only differentially expressed small RNA was miR199b (FDR; p = 0.002, log 2 FC; −4.3) which was increased in older donors and confirmed using qRT-PCR (p = 0.0085) (Fig.  2) .
Similar to the reports from our (Peffers et al., 2013a; Peffers et al., 2015) and other groups (Marioni et al., 2008) , quantification of transcripts by deep sequencing correlates with the results derived from qRT-PCR analyses reflecting the accuracy and reliability of deep sequencing analyses. There was no change in expression of the cellular senescence markers RBL1, p21, p16, p53 and p85 ( Table  7) . Table 5 . The DEG between young and old MSCs.
Positive log 2 fold change values represent lower expression in old MSCs, negative log 2 fold change values represent higher expression in old MSCs. FDR; false discovery rate.
Gene ontology (GO) and IPA analysis of DEGs and AS genes All DEGs (adjusted p < 0.05 and 1.4 log 2 fold change) were analysed in DAVID. Significant annotations included terms 'developmental protein', 'cell proliferation' and skeletal system morphogenesis. The DEGs were input into IPA (Peffers et al., 2015) . Interesting age-related features were determined from the gene networks inferred. The topscoring network was 'embryonic development, organismal development, cellular function and maintenance' (Fig.  3) . The top diseases and biological functions are shown in Table 8 . Transforming growth factor β (TGFβ) was identified as a potential upstream regulator of some of the pathway effects identified. The genes podocalyxin (PODXL), homeobox B6 (HOXB6) and TGFα were identified as biological targets with expression pairing consistent with miR199 (Table 9) . GO analyses indicated enrichment in genes associated with metabolic processes in 12 out of the 23 genes identified as undergoing AS (Fig. 4) . Additionally 20 % of AS protein-coding genes were identified in PANTHER as transcription factors. Table 6 . Table contains the genes in which there was a significant difference in splicing events in ageing MSCs.
Comparison of the DNA methylome in ageing MSCs
Unsupervised hierarchical clustering revealed that young and old samples are largely distinguished by their DNA methylome (Fig. 5) . In total, 187 differentially methylated loci (DML) were identified, including 44 
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Values for quantitative real-time polymerase chain reaction (qRT-PCR) are the mean ± standard error of relative expression levels normalised to expression of RPS8 (to two decimal places Table 7 . Real-time polymerase chain reaction analysis of selected genes reveals good correlation with RNA-Seq results. Table 9 . Using Targetscan 6.2 for miR199 targets were identified in which the corresponding genes were also DEG in ageing MSCs.
Representative miRs were all hsa-miR-199a-5p. All were sites in the untranslated regions. Expression pairing relates to when the expression of miR199 and the corresponding target gene in the corresponding direction. Table 10 . Significant gene ontology terms from DAVID using DML as input data. Significant primary term results are with a Benjamini-Hochberg adjusted p value <0.05.
Fig. 6.
Top-scoring network derived from the 187 DMLs in ageing. Ingenuity pathway analysis (IPA) identified 'connective tissue development and function, embryonic development, organ development as the principal associated network functions with a score of 40. This is a graphical representation between molecules identified in our data in their respective networks. Green nodes; hypermethylated genes in older MSCs, red nodes; hypomethylated genes in older MSCs. Intensity of colour is related to higher fold-change. Key to the main features in the networks is shown.
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within CpG islands and 3 within promoters. 117 DMLs were hypomethylated and 70 hypermethylated in old. GO analysis of genes containing DMLs indicated enrichment in embryonic skeletal tissue morphogenesis pathways and the terms homeobox, developmental proteins, transcriptional regulation and tissue morphogenesis (Table 10 ). In IPA, the top scoring network was 'connective tissue development and function, embryonic development, organ development' (Fig. 6A) . The top diseases and biological functions were similar to those identified in the RNASeq analysis (Table  8) . There was also a significant enrichment for DML of genes involved in differentiation of cells and connective tissue and the proliferation of MSCs (Fig. 7) . The top two networks were connective tissue development and function, embryonic development, organ development (score 40), skeletal and muscular system development and function, embryonic development, organismal development (score 37).
The methylation of gene promoters and/or enhancers is known to correlate with decreased gene expression contrastingly methylation within non-enhancer regions of the gene body correlates with increased gene expression (Jjingo et al., 2012) . Therefore, we compared DEGs from RNASeq with location of DMLs. The DEGs HAND2, HOXB7 and TBX18 contained DMLs within the gene body. HOXB7 demonstrated decreased methylation in old samples with a decrease in gene expression in old; HAND2 demonstrated an increase in methylation and concurrent increase in gene expression. For the genes HOXB4, HOXB6 and MKRN3 that contained DMLs within promoter regions between young and old samples only MKRN3 demonstrated the expected inverse relationship with gene expression (Table 11) .
Proteomics
Protein Identification, label-free quantification 2,347 proteins were identified in combined samples from MSCs. Of these 777 were quantifiable using at least two unique peptides in Progenesis QI and 118 differentially expressed; 116 higher in old and 2 lower in old (Table 12A and B). Peptides clustered according to age with a principal component of 80 %. Interestingly the highest differentially expressed protein was superoxide dismutase 2 (SOD2) at 20.8 higher in old MSCs (Fig.8A) . This was validated with western blotting.
Gene ontology (GO) and IPA analysis of differentially expressed proteins GO analyses indicated enrichment in genes associated with mitochondria, metabolic processes and transcriptional regulation (Fig. 8B) . IPA identified the top-scoring network was 'developmental disorders and metabolic disease'. The top diseases and biological functions included energy production, increased cell survival and metabolic diseases (Table 7) . Age-related changes in oxidative state were identified by the canonical pathways mitochondrial dysfunction and oxidative phosphorylation. Interleukins-1 and -6 were identified as upstream regulators of apoptosis, Table 11 . Summary of genes and DML correlating relationships.
The 3'UTR is encompassed in the gene body. The promoter is classified as the 5'UTR up to 1500 bp upstream of the start codon. Fig. 7 . Differentiation of cells and connective tissue and MSC proliferation were identified as significantly enriched at the DML level. Green nodes; hypermethylated genes in older MSCs, red nodes; hypomethylated genes in older MSCs. Intensity of colour is related to higher fold-change. Key to the main features in the networks is shown. Table 12A . Differentially expressed proteins identified following database search using at least two unique peptides. Table 12B . Differentially expressed proteins identified following database search using at least two unique peptides. One of the top regulator effects networks, which explains how predicted upstream regulators cause the observed changes in protein expression explaining phenotypic or functional outcomes downstream. These causal hypotheses take the form of directionally coherent networks formed from the merger of upstream regulator networks with downstream effects networks. Mitogen activated protein kinase 1 (MAPK1) and peroxisome proliferator-activated receptor gamma (PPARG) were identified as upstream regulators of downstream inhibition of fibrosis and organismal death but activation of cell survival through a set of nine differentially expressed proteins.
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cell proliferation and mitochondrial damage activation (Fig. 8C) . Top regulatory effects networks included cell survival and reduced fibrosis in ageing (Fig. 8D) . Fig. 9 summaries major findings from the study.
Discussion
Major sources of cells for musculoskeletal tissue regeneration (both in vivo and in vitro) are adult MSCs (Natsu et al., 2004; Shirley et al., 2005) . Recent studies have revealed that MSC cell biology is influenced by biological ageing (Campagnoli et al., 2001) with MSCs from older donors having a shorter life-span, and a reduced proliferative and differentiation potential (Sethe et al., 2006) . Thus age-related changes to their functionality may contribute to musculoskeletal ageing; a major factor in many musculoskeletal diseases. Our study aimed to increase our understanding of age-related changes in the systems of biological components of MSCs at the RNA, epigenetic and protein level. This has identified common networks across scales enabling a 'big picture view' of MSC ageing. Previous investigations on ageing MSCs have been undertaken on a variety of subsets of stem cells with variable potentials and characteristics. The combinatorial effects of genomic, epigenetic and proteomic changes lead to a decline in cellular function, which in turn contributes to tissue dysfunction and ageing. Here, we used young and old MSCs that had been tested for 'stemness' at a number of levels, including analysis of a comprehensive panel of markers and differentiation assays, performed for each lot prior to inclusion. Furthermore, as the site of extraction can affect cell behaviour (Bork et al., 2010; Matsubara et al., 2004) , we used MSCs derived from alveolar bone. As low oxygen tension improves MSC vitality and metabolic state in culture (Estrada et al., 2012; Knuth et al., 2013) , all cell culture were undertaken in 5 % oxygen tension. Finally, as challenges arise in distinguishing ageing in vivo and in vitro, we used the same passage number for all donors from identical seeding densities and confluence that can influence cellular ageing . It is worth noting that whilst one study found no difference between passage 2 and 10 in proliferation capacity and differentiation potential in MSCs (Bruder et al., 1997) , others demonstrated a reduction in colony forming units from passage 4 (Peter et al., 2012) .
There is a detrimental effect on MSC clonogenicity, proliferation capacity and differentiation potential when expansion is undertaken. Our studies were undertaken on ageing MSCs in in vitro conditions, which will produce different results from MSCs within an in vivo physiological environment. However, in order to obtain enough cells to undertake the systems biology approach used in our study, this was required. It would be beneficial to repeat the study on freshly isolated MSCs, in order to predict their ageing before expansion. As insufficient cell numbers would be problematic, this could be undertaken in a more targeted workflow in the future, but was beyond the scope of this study. Furthermore, although we have identified molecular changes at a number of levels, a validation of the system is required. As ageing can affect MSC differentiation potential in further work we have undertaken transcriptomic, proteomic and epigenetic analysis of changes in chondrogenic, osteogenic and tenogenic constructs produced from the young and old MSCs utilised in this study.
One of the main challenges of this study was the integration of the different types of data. We used network analysis and annotation of the pathways identified. However, we were unable to integrate key environmental factors such as nutrition and other lifestyle factors; affecting the pathways due to limited information on the donors. These factors can change molecular measurements. Other potential limitations include small sample size and significance threshold filtering, which can affect the subsequent pathway/network analysis. Additional parameters, such as histone modification, would benefit the study but this was beyond the financial scope of the study. Dynamic histone methylation can contribute to the ageing process through influencing DNA repair and transcriptional Our study found weak age-related effects on expression at the miR level. Despite this, an added benefit of using smallSeq was that we identified for the first time, in an unbiased manner, a catalogue of miRs and small nucleolar RNAs expressed in MSCs and their relative expression levels which will be a useful tool in future studies. Results contrast to a recent study in monkeys that identified 40 differentially expressed miRs in ageing by microarray (Yu et al., 2011) . This could be due to species, platform and workflow differences. The differential expression of miR-199 has been previously reported in this study and human MSC ageing (Alt et al., 2012 ). Here we demonstrate the age-related increase in miR-199b-5p expression. Analysis of miR predicted target genes and networks demonstrates that miR-199b-5p may be involved in regulating SIRT1, TGFα and PODXL. The expression of other predicted targets: MAB21L and EPHA7, was negatively correlated with that of miR-199b-5p during ageing, suggesting that these may indeed be targets. Interestingly, TGFα has been shown to mediate secretion of VEGFA by MSCs, positively contributing to processes like wound healing and injury response (Wang et al., 2008) . Moreover, SIRT1 appears to regulate the differentiation of MSCs (Simic et al., 2013) and their long-term growth (Yuan et al., 2012) . Together, these data support the hypothesis that age-related upregulation of miR-199b-5p expression in MSCs may contribute to age-related deterioration of MSC function through regulating key genes.
In transcriptomic studies, it is difficult to justify each individual change at the gene level. Generally, it is more informative to look at the changes as a whole. Therefore, we used gene ontology and network analysis tools. However, there are a few interesting findings for the some individual genes. We investigated the levels of gene expression previously reported to be associated with cellular senescence: p16, p21, Rb, p53 and p85. Previous studies have found increased levels of p21 and p53 in ageing MSCs (Stolzing et al., 2008; Zhou et al., 2008) , although none of these were significantly changed in ageing in this study. This may be due to differences in individual studies or the variability in the expression between individuals, especially apparent in MSCs from older individuals. ALX1 has the most reduced expression change in old. This gene is important in skeletal development and has previously demonstrated to have increased expression in old tendon (Peffers et al., 2015) and in bone-marrow-derived MSCs compared to those derived from umbilical cord (Hsieh et al., 2010) . The most highly DEGs in the old were CPC5 (involved in cell division and growth regulation), ADH1B (an enzyme able to metabolise many substrates) and OGN (an osteoblastic differentiation gene). We found age-related changes in gene profiles included differences in cell proliferation, signalling, function and maintenance. These changes suggest an age-related loss in MSCs ability to respond to biological cues. In addition, there was a dysregulation of transcription factors at the transcript and AS level in ageing with a reduction in expression of ALX1, PITX2, HOXB6, HOXB7, IRF6 and an increased expression of TBX18 and FOXP2 in ageing. Transcription factors, including HOX genes have been implicated in ageing of tissues (Stelnicki et al., 1998) including tendon (Peffers et al., 2015) , and heart (Bodyak et al., 2002) . Interestingly, HOX genes are an intrinsic property of MSCs and play a role in cellular identity, are required for tissue appropriate regeneration (Ackema and Charite, 2008; Sagi et al., 2012) and may be involved in the timing of ageing (Bork et al., 2010) . Loss of cellular identity, through alterations in HOX gene expression (Trivedi et al., 2011) , results in aberrant cellular homeostasis and age-related functional deterioration. Conversely, HOXmediated transcriptional memory limits stem cell-mediated tissue regeneration (Chang, 2009) . Potentially, the altered expression in ageing may affect the differentiation potential of older MSCs particularly in relation to osteogenesis (Shi et al., 1999) . This has particular relevance to both tissue engineering and musculoskeletal repair in ageing.
There is a disruption of splicing with ageing (Harries et al., 2011) . We have previously observed an age-associated disruption to the balance of alternatively expressed isoforms for selected genes in tendon ageing (Peffers et al., 2015) . Alterations in the splicing patterns of the mRNA transcripts contribute to some age-related diseases, including Hutchison Gilford Progeria syndrome (Eriksson et al., 2003) and Alzheimer's . Thus, whilst most MSCs may be expressing genes at comparable levels in MSC ageing, there are also differences in the relative balance of splice products or increase in the occurrence of atypical transcripts. Interestingly, ontology analysis identified AS genes altered in ageing primarily affected metabolic processes similar to that in ageing brain (Tollervey et al., 2011) .
We identified two differentially regulated LNCs in MSC ageing; AC004870.4 and RP11-670E13.5. LNCs (Long Noncoding RNA) are a diverse group of non-protein coding RNA molecules longer than 200 nucleotides whose expression is developmentally regulated and both cell and tissue specific. The function of the majority of LNCs is unknown. However, they have been implicated in many diseases (Ponting et al., 2009) . Studies have revealed that LNCs have significant roles in biological processes, including, transcription, imprinting, chromatin modification (Kung et al., 2013) . Furthermore, they are important in controlling tissue differentiation . Previously, a study has identified differentially expressed LNCs in bone marrow versus periodontal ligament derived MSCs from young donors (Dong et al., 2014) . The expression of RP11-670E13.5 has been previously identified in bone marrow (Uhlen et al., 2015) . However, there is no expression data for RP11-670E13.5, also known as lnc-DGKE-2, in MSCs. There may be a significant role for LNCs in phenotypic regulators of MSC differentiation and they could aid the establishment of lineage specification through independent mechanisms (Tye et al., 2015) . LNCs represent potential biomarkers of disease and novel therapeutic targets for ageing, but much work is needed to elucidate their roles in MSC ageing.
Epigenetic processes have been implicated in ageing and age-related musculoskeletal diseases such as osteoarthritis (Rushton et al., 2014) . Here, we analysed DNA methylation; the most characterised epigenetic MJ Peffers et al. MSC multi-omics mechanism, which is primarily involved in gene regulation. Alterations in DML within ageing tissues (Calvanese et al., 2009; Zykovich et al., 2014) and cells (Fernandez et al., 2012) , as well as aged MSCs (Bork et al., 2010) , and following successive in vitro culture (reviewed (Bentivegna et al., 2013) ). Our study provides the most comprehensive DNA methylation analysis of ageing MSCs, to date, using the HumanMethylation 450 Beadchip array. This has advantages over the 27K array used previously (Bork et al., 2010) as the 27K array contains probes within promoters only, whereas the 450K array includes probes within multiple genomic features as well as less dense CpG regions. Most methylation changes occurring in disease occur in the less dense CpG regions thus additional probes on the 450K array is advantageous. However, there was significant concordance with the results from this study. There was a global hypomethylation in ageing, as described previously (Calvanese et al., 2009) . Methylation changes in the study were associated with HOX genes, similar to other studies (Bork et al., 2010) , the expression of which is tightly regulated temporally during vertebrate development. An association between HOX genes and longevity has been previously proposed (Venkataraman and Futerman, 2002) . HOXB4, HOXB6 and HOXB7 were also DEGs in the RNASeq study. However, only for HOXB7 did DEG correlate (reduced in old) with DNA hypomethylation within the gene body. Despite this, the dysregulation of HOX genes at the mRNA and epigenetic level consolidate their role in MSC ageing. We identified many DMLs in genes involved in differentiation of cells and connective tissue as well as the proliferation of MSCs. The latter was also identified at the transcriptomic level. Methylation changes at specific CpG sites can affect MSC differentiation (Noer et al., 2007; Zimmermann et al., 2008) , whilst alterations in MSC potential have been previously noted (Khan and Marsh, 2009; Sethe et al., 2006) .
We did not observe a general correlation of DNA methylation with differentially expressed genes. This could be due to the differing sensitivities of the two platforms. It is commonly accepted that DNA methylation regulates gene expression. However, the effect of DNA methylation on gene expression is dependent upon the site of methylation. DNA methylation within the gene body or 3'untranslated region (UTR) of a gene generally positively correlates with gene expression, whereas methylation in the promoter is inversely correlated with gene expression. Others have hypothesised that DMLs at specific CpG sites does not inevitably correlate with gene expression changes. Significant gene expression fold-changes can only be anticipated if the CpG sites are principally methylated and that selective modification of certain promoter regions activate or inactivate binding of transcription regulators (Bork et al., 2010) . Further suggestions for the lack of correlation could be that a minimal number of altered DMLs are required in order to correlate with gene expression changes (Zykovich et al., 2014) or that methylation changes may reflect historical gene expression changes.
Interestingly, a recent report on reprogramming of old MSCs into induced pluripotent stem cells (iPS) and their subsequent re-differentiation into MSCs, indicated a reduction in some age-related MSCs features. Epigenetic recapitulation was maintained, with the age-affected DNA methylation accumulation remaining reset in iPS-MSCs (Frobel et al., 2014) .
The maintenance of the MSC proteome is imperative for assuring stem cell identity. Label-free quantification provided the most comprehensive proteomic analysis of ageing MSCs phenotype to date. Whilst studies imply that alterations in mRNA levels are a significant factor in the determination of protein changes, gene expression -as reflected by mRNA -is correlated with protein 40 % of the time (Web ref. 5 ). Protein expression is subject to a diversity of regulations of transcription and translation, including mRNA and protein half-life, translation rate, post-translational modifications and subcellular localisation. Furthermore, differences in sensitivity between platforms can also account for differences. In this study, there was minimal overlap at the RNA and protein at the individual molecule level but there were similarities at the functional level for many changes; metabolism, transcriptional regulation, energy metabolism, development, cell proliferation and cell survival in MSC ageing.
There was an age-related increase in proteins involved in anti-oxidant changes, energy, nucleic acid and fatty-acid metabolism, musculoskeletal abnormalities, increased cell survival and reduced cell death. A number of inflammatory cytokines were upregulated in ageing (TGFα at the gene level) or identified as upstream regulators at the gene (IL6, TNF) and protein level (IL4, IL6, IL1β). Together, these findings, indicate that MSCs undergo inflamm-ageing (reviewed by: Lepperdinger, 2011) . Furthermore, similar to others, mitochondrial ageing (Kasper et al., 2009 ) was demonstrated.
Mitochondrial dysfunction is a hallmark of the ageing phenotype, and alterations in redox balance may, in part, explain the observed reduction in cellular function associated with age (Chan, 2006) . The differences in mitochondrial protein expression could be indicative of potentially dysfunctional mitochondrial alterations in ageing. A key finding of this study was a large increase in mitochondrial superoxide dismutase (SOD2) protein expression in ageing, which is in contrast to others (Duscher et al., 2014; Stolzing et al., 2008) . The mitochondria are a primary source of reactive oxygen species (ROS) and SOD2 represents the principle antioxidant molecule that scavenges mitochondrial superoxide, thus of key importance in maintaining redox balance (Miao and St Clair, 2009 ). An increase in SOD2 protein was associated with an increase in mitochondrial peroxiredoxin 3, a key scavenger of H 2 O 2 , which suggests that in this study, the antioxidant capacity of ageing cells increases similar to rat ageing cartilage (Fu et al., 2013) , but in contrast to other studies (Duscher et al., 2014; Stolzing et al., 2008) . This observation may be a compensatory response by the cell to restore oxidative balance, given that our data also demonstrate increased protein expression of many mitochondrial proteins. This includes members of the electron transport chain; crucial for mitochondrial homeostasis. Whether or not the increase in mitochondrial MJ Peffers et al. MSC multi-omics antioxidant proteins correlates with increased activity is beyond the scope of this study, but represents a future avenue of research for our group. Alternatively, the dramatic increase in SOD2 levels may be evidence of mitochondrial dysfunction, potentially exposing the cell to large amounts of H 2 O 2 , which could enhance oxidative stress and cause aberrant H 2 O 2 -mediated redox signalling (Veal et al., 2007) . There was a reduction in proteasome subunits PSMB7, PSMA5 and PSMD2 in ageing MSCs. This has previously been associated with reduced proteasome activity in ageing fibroblasts (Hwang et al., 2007) . Furthermore, PSMB7 silencing induces autophagy in cardiomyocytes (Kyrychenko et al., 2014) . Cellular damage and dysfunction can be caused by defects in proteostasis, resulting in the accumulation of damaged proteins (Bucciantini et al., 2002) . The age-dependant deficits evident here in the proteasome subunits may affect both protein quality and autophagy, contributing to MSC ageing.
Conclusion
Our data suggest that age-related changes in MSCs result in impaired therapeutic potential of aged progenitor cells. These results have significant implications for therapeutic cell source decisions (autologous or allogeneic) revealing the necessity of approaches to improve functionality of ageing MSCs.
